Skip to main content

RELAB Skin

RELAB Skin offers a skincare system powered by Effector Proteins, a patented class of cell-permeable proteins engineered to penetrate the skin barrier and directly target the NLRP3 inflammasome—the cellular trigger behind psoriasis-related inflammation. The regimen includes Active Rescue Psoriasis Cream for flare-ups and Barrier Restore creams for ongoing support, with clinical study results showing visible improvements in skin appearance after one month of twice-daily use.

Traction –/10
New York City, United States · HQ
410+ followers
  • Biotechnology
  • Consumer Goods
  • Healthcare Technology
Updated 11 days ago

Funding

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Psoriasis and other inflammatory skin conditions are driven by hyperactivated cellular signaling that originates deep within cells, not at the skin's surface. Traditional skincare products only treat surface symptoms and fail to interrupt the underlying inflammatory cascade, leaving patients to manage recurring flare-ups without addressing their root cause.

Solution

RELAB provides a skincare system powered by Effector Proteins, a new class of naturally occurring proteins re-engineered to penetrate the skin barrier, enter cells, and directly target the NLRP3 inflammasome—the biological trigger behind inflammatory cycles associated with psoriasis. The products act as molecular messengers that help regulate inflammatory signaling, calming active flare-ups while strengthening the skin barrier between episodes to reduce the likelihood of future inflammation. The regimen includes Active Rescue Psoriasis Cream for active inflammation and Barrier Restore creams for ongoing support, both designed for daily use and compatibility with sensitive, reactive skin. Clinical and consumer studies report improvements in skin appearance, reduced itchiness and scaling, and higher effectiveness compared to other psoriasis care products.

Target Audience

Primary users are adults living with psoriasis and other inflammatory skin conditions who seek a science-backed, non-prescription approach to managing flare-ups, as well as individuals with sensitive, reactive skin looking for barrier-supporting daily skincare.

Features

  • Effector Proteins that penetrate the cell membrane and directly target the NLRP3 inflammasome and caspase-1 pathway
  • Targets inflammatory messengers IL-1β and IL-18 to interrupt the inflammatory cascade at its source
  • Active Rescue Psoriasis Cream formulated for acute flare-ups to calm redness, scaling, and discomfort
  • Barrier Restore Body and Face Creams designed to maintain skin resilience and balance between flare-ups
  • Dermatologist-administered clinical study with twice-daily application demonstrating visible improvements over one month
  • Non-prescription, over-the-counter availability suitable for daily use and integration with existing routines
This profile is AI-generated and may contain inaccuracies.